[{"NetIncomeLoss_1_Q1_USD":3793000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-693000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":22212000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-1184000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-10000.0,"AssetsCurrent_0_Q1_USD":133518000.0,"LongTermDebtCurrent_0_Q1_USD":26260000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":17607000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":471000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":3341000.0,"InventoryValuationReserves_0_Q1_USD":659000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":-1619000.0,"UnrecognizedTaxBenefits_0_Q1_USD":2127000.0,"CommonStockSharesIssued_0_Q1_shares":168798000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":8385000.0,"Assets_0_Q1_USD":218457000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-10000.0,"ShareBasedCompensation_1_Q1_USD":1605000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":4285000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1_Q1_USD":3.17,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"DeferredIncomeTaxAssetsNet_0_Q1_USD":46392000.0,"InterestPaidNet_1_Q1_USD":850000.0,"PreferredStockValueOutstanding_0_Q1_USD":null,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":10904000.0,"ContractWithCustomerAssetNetCurrent_0_Q1_USD":10960000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":2.53,"EarningsPerShareBasic_1_Q1_USD":0.02,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":174908000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-46000.0,"AccountsReceivableNetCurrent_0_Q1_USD":42940000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":590000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q1_USD":0.0,"DepreciationDepletionAndAmortization_1_Q1_USD":894000.0,"RevenueRemainingPerformanceObligation_0_Q1_USD":14748000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":1722000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"IncreaseDecreaseInInventories_1_Q1_USD":1398000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":502000.0,"OtherAssetsNoncurrent_0_Q1_USD":2498000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":55652000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":4597000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":344063000.0,"Liabilities_0_Q1_USD":92232000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"SharesPaidForTaxWithholdingForShareBasedCompensation_1_Q1_shares":348000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":2.39,"AccruedLiabilitiesCurrent_0_Q1_USD":26373000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":3783000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":2640000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-650000.0,"CommonStockValueOutstanding_0_Q1_USD":1688000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":1605000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":1978000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":325000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":167822000.0,"LiabilitiesCurrent_0_Q1_USD":72144000.0,"AccountsPayableCurrent_0_Q1_USD":16764000.0,"NonoperatingIncomeExpense_1_Q1_USD":-1008000.0,"InterestExpense_1_Q1_USD":962000.0,"IncreaseDecreaseInContractWithCustomerAsset_1_Q1_USD":2820000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":4352000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1_Q1_USD":-1000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":3341000.0,"LongTermDebtNoncurrent_0_Q1_USD":14765000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":7488000.0,"IncomeLossFromContinuingOperationsPerDilutedShare_1_Q1_USD":0.02,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q1_shares":7086000.0,"IncreaseDecreaseInDeferredIncomeTaxes_1_Q1_USD":-590000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":55652000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":1779000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q1_USD":16293000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":24276000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":1619000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":4383000.0,"OtherOperatingActivitiesCashFlowStatement_1_Q1_USD":126000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":11061000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":42083000.0,"OperatingIncomeLoss_1_Q1_USD":5391000.0,"InventoryNet_0_Q1_USD":19614000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":1570000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":2.16,"LiabilitiesAndStockholdersEquity_0_Q1_USD":218457000.0,"PreferredStockSharesAuthorized_0_Q1_shares":3000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1_Q1_shares":15000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1177000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":1136000.0,"CommonStockSharesAuthorized_0_Q1_shares":300000000.0,"ProfitLoss_1_Q1_USD":3793000.0,"StockholdersEquity_0_Q1_USD":126225000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":1184000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":13961000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":9431000.0,"IncomeLossFromContinuingOperationsPerBasicShare_1_Q1_USD":0.02,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-218833000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":2515000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":731000.0,"CommonStockSharesOutstanding_0_Q1_shares":168798000.0,"EarningsPerShareDiluted_1_Q1_USD":0.02,"OtherLiabilitiesNoncurrent_0_Q1_USD":726000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-2369000.0,"Ticker":"ATRS","CIK":"1016169","name":"ANTARES PHARMA, INC.","OfficialName":"Antares Pharma Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"948492298.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"nan","filed":"20210506"}]